Loading news...
Cibc World Market Inc. grew its position in Elevance Health, Inc. (NYSE: ELV) by 24.4% in the undefined quarter, according to its most recent filing with the SEC. The firm owned 19,807 shares of the company's stock after buying an additional 3,879 shares during the period. Cibc World Market Inc.'s holdings in Elevance
Caprock Group LLC bought a new position in shares of Elevance Health, Inc. (NYSE: ELV) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 5,140 shares of the company's stock, valued at approximately $1,638,000. Several other institutional investors have also modified their
Assetmark Inc. increased its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 28.2% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 86,775 shares of the company's stock after acquiring an additional 19,078 shares during the quarter. Assetmark Inc.'s
Insight into Seth Klarman (Trades, Portfolio)'s Fourth Quarter 2025 Investment Decisions Seth Klarman (Trades, Portfolio) recently submitted the 13F filing for
Ashton Thomas Private Wealth LLC lessened its position in Elevance Health, Inc. (NYSE: ELV) by 79.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 622 shares of the company's stock after selling 2,365 shares during the period.
Advisors Asset Management Inc. increased its position in Elevance Health, Inc. (NYSE: ELV) by 16.9% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 35,545 shares of the company's stock after purchasing an additional 5,143 shares during the quarter. Advisors Asset Management Inc.'s
Blume Capital Management Inc. grew its stake in Elevance Health, Inc. (NYSE: ELV) by 236.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,145 shares of the company's stock after acquiring an additional 4,320 shares during the quarter. Blume Capital Management
Insightful Moves in the Fourth Quarter of 2025 Manning and Napier Group, LLC (Trades, Portfolio) recently submitted its 13F filing for the fourth quarter of 2025
Investors need to pay close attention to ELV stock based on the movements in the options market lately.
Top 15 High-Growth Dividend Stocks For February 2026
Weekly Market HighlightsMarket breadth was negative with 4,094 advancers versus 5,526 decliners, pointing to a broadly weaker tape despite pockets of strength.
Stock News Warsh tapped for Fed: U.S. markets (SPY) steadied after President Donald Trump named former governor Kevin Warsh to succeed Jerome Powell as Federal
Elevance Health (NYSE: ELV) executives emphasized "execution and repositioning" as the central theme for 2026, outlining a guidance framework that reflects portfolio actions across Medicaid, Medicare Advantage, and the individual ACA market alongside continued investment in Carelon. On the company's fourth-quarter 2025 earnings call, management also reiterated expectations to return to at least 12% adjusted EPS
Guru Stock PicksRichard Pzena has made the following transactions:Reduce in DG by 7.65%Add in TSN by 11.78%Stock News U.S. trade gap jumps: The U.S. trade defic
Elevance Health Inc (NYSE:ELV) stock yesterday enjoyed its biggest single-day percentage gain since May 2024 after reporting $547 million in profits, but it wasn't enough to erase its worst day since March 2020 in the previous session, after the Centers for Medicare & Medicaid Services proposed to raise Medicare Advantage payment rates by only 0.09% in 2027.
Elevance Health, Inc. (NYSE: ELV - Get Free Report)'s stock price rose 6.3% on Wednesday following a stronger than expected earnings report. The stock traded as high as $343.86 and last traded at $343.3750. Approximately 1,829,465 shares were traded during mid-day trading, an increase of 17% from the average daily volume of 1,561,448 shares. The stock
Guru Stock PicksMurray Stahl has made the following transactions:Reduce in CVEO by 8.96%Add in SJT by 11.03%Eaton Vance Worldwide Health Sciences Fund has made
Adjusted Diluted Earnings Per Share (EPS): $3.33 for Q4 2025; $30.29 for the full year 2025.Operating Revenue: $49.3 billion for Q4 2025, a 10% increase from t
ELV tops Q4 EPS estimates as premiums grow and Carelon revenues surge, even as medical membership slips and expenses climb.
Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript